CD8A and glioma: Interestingly, in high‐risk glioma patients, the immune gene sets associated with immune promoting (TIL, CD8+ T cells, etc.)and immune‐suppressing (Treg, APC co‐inhibition, etc.)tumor immunity were both upregulated, but the prognosis was worse in high‐risk glioma patients as immunosuppression was positively correlated with risk score.